Johnson & Johnson subsidiary acquires Emerging Implant Technologies to expand spine implants portfolio: 5 insights

Written by Mackenzie Garrity | September 12, 2018 | Print  |

Johnson & Johnson subsidiary GmbH acquired Emerging Implant Technologies.

Here are five insights:

1. Emerging Implant Technologies manufactures 3D-printed titanium interbody implants for spinal fusion surgery.

2. With the acquisition, J&J's DePuy Synthes will enhance its interbody implant portfolio, which includes titanium integrated PEEK technology and now 3D-printed cellular titanium.

3. J&J said Emerging Implant Technologies will complement DePuy Synthes' existing spine interbody segment, including its Concorde Lift Expandable Interbody Device and Proti 360 Family of Titanium-Integrated Interbody Implants.

4. The acquisition allows DePuy Synthes to move forward as a leader in treating spinal diseases.

5. "Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patients," said DePuy Synthes Group Chairman Aldo Denti.

"We are excited to welcome the skilled team at [Emerging Implant Technologies], and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion procedures reliably and with consistent outcomes."

More articles on devices and implants:
Stryker, Fuse Medical & more: 7 device company mergers, acquisitions and agreements
LimaCorporate acquires TechMah Medical, aims to expand digital orthopedics technology: 4 details
Stryker to purchase Invuity for $190M in 2nd acquisition deal in 2 weeks: 5 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months